68Ga-DOTA-Tyr3-Octreotide PET for Assessing Response to Somatostatin-Receptor–Mediated Radionuclide Therapy-Reference-Cited by-同舟云学术

68Ga-DOTA-Tyr3-Octreotide PET for Assessing Response to Somatostatin-Receptor–Mediated Radionuclide Therapy

Published:2009-08-18 Issue:9 Volume:50 Page:1427-1434
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Gabriel Michael,Oberauer Andreas,Dobrozemsky Georg,Decristoforo Clemens,Putzer Daniel,Kendler Dorota,Uprimny Christian,Kovacs Peter,Bale Reto,Virgolini Irene J.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference25 articles.

1. Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours

2. Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors

3. Quality of Life in Patients With Gastroenteropancreatic Tumors Treated With [177Lu-DOTA0,Tyr3]octreotate

4. Epidemiology and survival in patients with carcinoid disease in the Netherlands

5. A 5-decade analysis of 13,715 carcinoid tumors

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective evaluation of the predictive value of tumour burden at baseline [68 Ga]Ga-DOTA-TOC or -TATE PET/CT and tumour dosimetry in GEP-NET patients treated with PRRT;EJNMMI Reports;2024-08-08

2. Models using comprehensive, lesion-level, longitudinal [68Ga]Ga-DOTA-TATE PET-derived features lead to superior outcome prediction in neuroendocrine tumor patients treated with [177Lu]Lu-DOTA-TATE;European Journal of Nuclear Medicine and Molecular Imaging;2024-05-25

3. Radionuclide Theranostics in Neuroendocrine Neoplasms: An Update;Current Oncology Reports;2024-04-06

4. Parametric net influx rate imaging of 68Ga-DOTATATE in patients with neuroendocrine tumors: assessment of lesion detectability;Annals of Nuclear Medicine;2024-04-04

5. Evaluating Prognosis of Gastrointestinal Metastatic Neuroendocrine Tumors: Constructing a Novel Prognostic Nomogram Based on NETPET Score and Metabolic Parameters from PET/CT Imaging;Pharmaceuticals;2024-03-14